Parallax Volatility Advisers’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-19,588
Closed -$248K 2179
2024
Q2
$248K Sell
19,588
-6,607
-25% -$66.5K ﹤0.01% 1581
2024
Q1
$125K Sell
26,195
-86,016
-77% -$399K ﹤0.01% 1588
2023
Q4
$539K Buy
112,211
+45,883
+69% +$281K ﹤0.01% 1579
2023
Q3
$480K Buy
+66,328
New +$530K ﹤0.01% 1619
2022
Q3
Sell
-70,681
Closed -$3.06M 3276
2022
Q2
$3.63M Buy
70,681
+39,758
+129% +$2.06M ﹤0.01% 1094
2022
Q1
$2.28M Sell
30,923
-174,010
-85% -$15.5M ﹤0.01% 1313
2021
Q4
$29.3M Buy
204,933
+140,213
+217% +$24.1M 0.03% 337
2021
Q3
$13.4M Buy
64,720
+41,228
+175% +$9.09M 0.01% 551
2021
Q2
$4.99M Buy
23,492
+22,580
+2,476% +$4.14M 0.01% 664
2021
Q1
$165K Sell
912
-73,305
-99% -$14.6M ﹤0.01% 1091
2020
Q4
$8.28M Buy
74,217
+70,728
+2,027% +$7.52M 0.01% 783
2020
Q3
$378K Buy
+3,489
New +$425K ﹤0.01% 2341
2019
Q4
Sell
-11,295
Closed -$49K 2569
2019
Q3
$57K Buy
+11,295
New +$61.8K ﹤0.01% 2062
2019
Q2
Sell
-8,836
Closed -$69.5K 3352
2019
Q1
$97K Sell
8,836
-40,025
-82% -$1.26M ﹤0.01% 2124
2018
Q4
$1.8M Buy
+48,861
New +$1.89M ﹤0.01% 1096
2018
Q1
Sell
-2,148
Closed -$53K 3597
2017
Q4
$53K Buy
+2,148
New +$52.4K ﹤0.01% 3201
2015
Q1
Sell
-1,959
Closed -$232K 5136
2014
Q4
$232K Sell
1,959
-1,187
-38% -$124K ﹤0.01% 2719
2014
Q3
$262K Buy
+3,146
New +$284K ﹤0.01% 2285

Other funds holding NVAX

Parallax Volatility Advisers's NVAX Position: Q3 2024 in Review

Parallax Volatility Advisers sold out of Novavax (NVAX) in Q3 2024, closing a stake of 19,588 shares — an estimated $248K sold.

Parallax Volatility Advisers first reported a position in NVAX in Q3 2014 and held it in 18 quarters. The position peaked at $29.3M in Q4 2021. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

  • Parallax Volatility Advisers reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 19,588 Novavax shares in Q3 2024, an estimated $248K.
  • Parallax Volatility Advisers first reported a position in Novavax in Q3 2014 and held it in 18 quarters.
  • Parallax Volatility Advisers's Novavax position peaked at $29.3M in Q4 2021.
  • 237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on Parallax Volatility Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.